Natures Sunshine | 8-K: FY2025 Q3 Revenue Beats Estimate at USD 128.34 M

Revenue: As of FY2025 Q3, the actual value is USD 128.34 M, beating the estimate of USD 120.3 M.

EPS: As of FY2025 Q3, the actual value is USD 0.3, beating the estimate of USD 0.16.

EBIT: As of FY2025 Q3, the actual value is USD 8.975 M.

Segment Revenue

• Asia: Revenue increased by 17.1% to $64.7 million from $55.3 million in the same quarter last year.
• Europe: Revenue increased by 12.7% to $22.1 million from $19.6 million.
• North America: Revenue increased by 7.7% to $36.2 million from $33.6 million.
• Latin America and Other: Revenue decreased by 13.1% to $5.3 million from $6.1 million.

Operational Metrics

• Net Income: GAAP net income attributable to common shareholders was $5.3 million, up from $4.3 million in the previous year.
• Gross Margin: Increased to 73.3% from 71.3% in the previous year, driven by cost savings initiatives and favorable foreign exchange.
• Operating Income: Increased to $9.0 million, or 7.0% of net sales, from $5.3 million, or 4.6% of net sales, in the previous year.
• Adjusted EBITDA: Increased by 42% to $15.2 million from $10.7 million.

Cash Flow

• Operating Cash Flow: Net cash provided by operating activities was $25.4 million for the nine months ended September 30, 2025, compared to $13.1 million in the prior year period.
• Capital Expenditures: Totaled $4.1 million for the nine months ended September 30, 2025, compared to $8.8 million in the prior year period.

Unique Metrics

• Digital Sales: A 52% year-over-year increase in digital sales was noted, attributed to strategic investments in North America Digital.

Outlook / Guidance

Nature’s Sunshine raised its full-year outlook, expecting 2025 net sales to range between $476 - $480 million, up from the previous guidance of $460 - $475 million. Adjusted EBITDA is expected to range between $47 - $49 million, up from the prior guidance of $41 - $45 million.